Moderna Co‑Founder Bets Big on mRNA’s Cancer-Vaccine Promise
TL;DR
Moderna co-founder Kenneth Chien remains bullish on mRNA’s potential, predicting an mRNA cancer vaccine could reshape oncology and lift the entire field, even as past Moderna–AstraZeneca deals failed to deliver the planned drugs.
Want the full story? Read the original reporting
Read on statnews.com